Position in NAGE
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$1,474,756
+$1,295,462 QoQ
Shares Held
334,412
+1086.2% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OP Asset Management Ltd holds $58,432,294 across 25 Biotechnology names. NAGE ranks #13 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,189 | $11,694,436 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,139 | $10,924,356 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,477 | $7,767,834 | |
| 4 | INSM |
INSMED Inc
|
22,222 | $3,633,741 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,633 | $3,270,809 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
56,060 | $3,166,829 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
609,112 | $2,405,992 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
33,602 | $2,289,304 |
All Filings in NAGE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,474,756 | 334,412 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $179,294 | 28,191 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||